NeueHealth, Inc. (NYSE:NEUE) CEO George Lawrence Mikan III Sells 31,798 Shares

NeueHealth, Inc. (NYSE:NEUE) CEO George Lawrence Mikan III sold 31,798 shares of the company’s stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $7.33, for a total transaction of $233,079.34. Following the completion of the transaction, the chief executive officer now directly owns 146,539 shares in the company, valued at $1,074,130.87. The trade was a 17.83 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

George Lawrence Mikan III also recently made the following trade(s):

• On Tuesday, December 17th, George Lawrence Mikan III sold 16,803 shares of NeueHealth stock. The shares were sold at an average price of $4.18, for a total transaction of $70,236.54.

NeueHealth Stock Performance

Shares of NYSE NEUE traded up $0.05 during trading on Wednesday, reaching $7.45. The stock had a trading volume of 38,124 shares, compared to its average volume of 70,685. The business’s 50-day moving average price is $5.47 and its 200-day moving average price is $5.38. NeueHealth, Inc. has a fifty-two week low of $3.79 and a fifty-two week high of $16.59. The company has a market cap of $61.72 million, a P/E ratio of -0.15 and a beta of 0.57.

Hedge Funds Weigh In On NeueHealth

Institutional investors have recently bought and sold shares of the company. Partners Group Holding AG acquired a new stake in shares of NeueHealth during the third quarter worth about $463,000. Deer Management Co. LLC purchased a new stake in NeueHealth during the 2nd quarter worth approximately $5,436,000. NEA Management Company LLC acquired a new stake in NeueHealth during the 2nd quarter worth approximately $14,834,000. Finally, Renaissance Technologies LLC purchased a new position in NeueHealth in the 2nd quarter valued at approximately $312,000. 63.88% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Separately, Royal Bank of Canada lowered their price objective on shares of NeueHealth from $8.00 to $7.00 and set a “sector perform” rating for the company in a research report on Monday, December 9th.

NeueHealth Company Profile

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.